novartis glp 1 drug Novo Nordisk's weight-loss pill wins FDA approval FDA moves to stop compounding

The term Ozempic face has emerged on social media, bringing widespread attention to the aesthetic issues associated with rapid weight loss induced by these medications, said Deepak Ramesh, MD, FACS

Q9: Is liposomal glutathione better absorbed than L-glutathione

At Genesis Drug Discovery & Development (GD), our teams work alongside biotech and pharmaceutical partners to support preclinical IBD research through integrated pharmacology, disease modeling, biomarker analysis, bioanalytical services, and translational research capabilities

Trigger factors for spontaneous intracerebral hemorrhage: a case-crossover study